Ceribell, Inc. (CBLL) intrinsic value & 10-year financials

Ceribell, Inc. (CBLL) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 4 fiscal years revenue grew 40.3% a year to $89.1M, with an average return on invested capital of -9.1%.

Graham intrinsic value
—
Share price (Oct 17, 2026)
$25.04
Market cap
$915.0M
Revenue (FY2025)
$89.1M
Revenue growth (4-yr CAGR)
40.3%
ROIC (10-yr avg)
-9.1%
Free cash flow (FY2025)
-$41.6M

CBLL 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $89.1M -$53.4M -$1.46 -$41.6M -65.6% -102.2%
FY2024 $65.4M -$40.5M -$1.13 -$36.4M -60.7% 54.0%
FY2023 $45.2M -$29.5M -$1.85 -$30.1M -66.4% 20.7%
FY2022 — — — — — —

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

Ceribell, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.

Ceribell, Inc. has historically struggled to out-earn its cost of capital, averaging just -9.1% ROIC.

Ceribell, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, Ceribell, Inc. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-48.49 per share.

CBLL stock: frequently asked questions

What is the intrinsic value of Ceribell, Inc. (CBLL) stock?

Graham's formula only works with positive earnings. Ceribell, Inc. reported diluted EPS of -$1.46 in fiscal 2025, so no Graham value is shown. The 10-year table shows revenue and cash-flow trends instead.

Does Ceribell, Inc. generate free cash flow?

Ceribell, Inc. generated -$41.6M of free cash flow (operating cash flow minus capital expenditures) in fiscal 2025. Free cash flow was positive in 0 of the last 3 reported years.

What is CBLL's return on invested capital?

Average ROIC over the last 4 fiscal years was -9.1%, and average return on equity was -34.6%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this CBLL data come from?

From Ceribell, Inc.'s annual 10-K filings on SEC EDGAR, most recently filed May 11, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar electromedical & electrotherapeutic apparatus stocks